CytomX Therapeutics (CTMX) Tax Rate (2015 - 2026)

CytomX Therapeutics (CTMX) has 10 years of Tax Rate data on file, last reported at 0.32% in Q1 2026.

• Quarterly Tax Rate fell 59.0% year-over-year to 0.32% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 6.11% (up 555.0% YoY) and the FY2025 annual result came in at 21.0%, up 2031.0% from the prior year.
• Tax Rate declined to 0.32% in Q1 2026, from 14.3% in the prior quarter.
• In the past five years, Tax Rate ranged from a high of 56.09% in Q4 2023 to a low of 69.23% in Q2 2025.
• A 4-year average of 4.56% and a median of 0.33% in 2024 frame the typical range for Tax Rate.
• The widest YoY moves for Tax Rate: up 1397 bps in 2025, down 6844 bps in 2025.
• Tracing CTMX's Tax Rate over 4 years: stood at 56.09% in 2023, then slumped by 99 bps to 0.33% in 2024, then soared by 4267 bps to 14.3% in 2025, then slumped by 102 bps to 0.32% in 2026.
• The last three Tax Rate figures came in at 0.32% (Q1 2026), 14.3% (Q4 2025), and 0.41% (Q3 2025), per Business Quant data.